Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1999
10/12/1999US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene
10/12/1999US5965355 Screening for grapevine leafroll-associcated virus 8 infection by binding the viral rna polypeptide with monoclonal antibody, detecting the bound antibody
10/12/1999US5965353 An epitope; for a diagnostic kit
10/12/1999US5965136 Bone resorption assay
10/12/1999US5965132 Methods and compositions for targeting the vasculature of solid tumors
10/12/1999US5965130 Inhibiting metastasis of a tumor in a mammal by administering intravenous immunoglobulin (inig) in a specific dosage either as a sole agent or in combination with other agent used in cancer treatment
10/12/1999US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer
10/12/1999US5965122 Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors
10/12/1999US5965120 Lymphocyte chemoattractant factor and uses thereof
10/12/1999CA1340787C Cdnas coding for members of the carcinoembryonic antigen family
10/12/1999CA1340781C Tumor specific monoclonal antibodies
10/07/1999WO1999050670A1 Pf-4 receptor assay
10/07/1999WO1999050661A2 Method and test kit for detecting central nervous system tissue in meat products
10/07/1999WO1999050637A2 Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof
10/07/1999WO1999050461A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999WO1999050427A2 Novel basal endosperm transfer cell layer (betl) specific genes
10/07/1999WO1999050421A1 Ubiquitin conjugating enzyme
10/07/1999WO1999050418A1 Treatment and diagnosis of staphylococcal infections
10/07/1999WO1999050416A1 Tnf-related death ligand
10/07/1999WO1999050407A1 Monoclonal antibody against human telomerase catalytic subunit
10/07/1999WO1999050301A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999WO1999050300A1 Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders
10/07/1999WO1999050297A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999WO1999050288A2 Mammalian blood loss-induced gene, kd312
10/07/1999WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999WO1999049889A1 Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane antigens
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999WO1999049840A1 Skin treatment compositions and the use thereof
10/07/1999WO1999049732A1 Immune cell regulation with src ptk sequestering agents
10/07/1999WO1999041614A3 Method for detecting intimin producing microorganisms
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs
10/07/1999WO1999024077A3 Compositions and methods for targeted delivery of biologically-active factors
10/07/1999WO1999023221A3 Multivalent antigen-binding proteins
10/07/1999DE19816395A1 Menschliche Nukleinsäuresequenzen aus Ovar-Normalgewebe Nucleic acid sequences from human ovarian normal tissue
10/07/1999DE19814860A1 Bakterielle Transglutaminasen Bacterial transglutaminases
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999CA2321179A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/07/1999CA2291798A1 Monoclonal antibody against human telomerase catalytic subunit
10/06/1999EP0947525A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
10/06/1999EP0946880A1 Method for diagnosis and therapy of hodgkin lymphomas
10/06/1999EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999EP0946731A1 Non-m non-o hiv strains, fragments and applications
10/06/1999EP0946728A1 Bone stimulating factor
10/06/1999EP0946727A1 Antibody mutants
10/06/1999EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946721A1 Human growth gene and short stature gene region
10/06/1999EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999EP0946717A1 Transgenic plants expressing assembled secretory antibodies
10/06/1999EP0946591A2 Cloned glucagon-like peptide-2 receptors
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0779933A4 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
10/06/1999EP0517815B1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
10/06/1999CN1230967A Process for producing plasma protein-containing medicament
10/06/1999CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes
10/06/1999CN1230591A Monoclone antibody cell strain and its monoclone antibody with hepatitis C virus resisting non-structure zone 4 antigen
10/06/1999CN1230549A Escape mutant of surface antigen of hepatitis B virus
10/05/1999US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999US5962664 Psychosis protecting nucleic acid, peptides, compositions and method of use
10/05/1999US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum
10/05/1999US5962644 Porcine CD34
10/05/1999US5962643 Integrin β subunit and uses thereof
10/05/1999US5962639 Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
10/05/1999US5962637 Toxin assay
10/05/1999US5962424 Inducing selectin expression using ionizing radiation
10/05/1999US5962420 Wound healing agents; drug delivery; crosslinking fibrin
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5962316 Cell-cycle regulatory proteins, and uses related thereto
10/05/1999US5962312 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/05/1999US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999US5962300 Polynucleotide which encodes a polypeptide tumor suppressor; for diagnosis, prevention, and treatment of cancer, eczema, psoriasis, psoriasis, scleroderma, dermatitis, skin atrophy, and other skin disorders; anticarcinogenic agents
10/05/1999US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses.
10/05/1999US5962274 Recombinant nucleic acid from simian virus 5 genome; does not express functional membrane bound hemaglutinin neuraminidase protein but fusion of cytoplasmic and membrane domains of protein and exogenous extracellular cell targeting protein
10/05/1999US5962269 Methods for producing antibodies which specifically bind to interleukin-9 receptor
10/05/1999US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system.
10/05/1999US5962260 Recombinant production of human and bovine receptors for modified low-density lipoprotein
10/05/1999US5962259 Response regulator polynucleotides
10/05/1999US5962257 Flea aminopeptidase nucleic acid molecules
10/05/1999US5962255 Allowing recombination between vectors coding for polypeptide chains of specific binding pairs (e.g. antibodies); for production of libraries of secreted replicable genetic display packages with antibodies on surface
10/05/1999US5962246 Isolated protein which is deoxyuridine triphosphatase, an enzyme important in cell proliferation; for use as marker to give accurate information about the status of cells or tissues
10/05/1999US5962241 Monoclonal antibody detection of proteins on sperm related to fertility
10/05/1999US5962240 Mycobacterium proteins and applications
10/05/1999US5962236 Immunoassay using antibodies against free lysyl pyridinoline cross-links in unhydrolyzed urine sample
10/05/1999US5962232 Protein kinase molecules
10/05/1999US5962230 Diagnosis and treatment of glaucoma
10/05/1999US5962026 Solid compositions of fibrin monomer
10/05/1999US5961985 Vaccine and serum for endotoxin associated disease immunization and treatment, detoxified endotoxin, and bacterial mutant
10/05/1999US5961984 Human T-cell lymphotropic virus type I envelope protein and human monoclonal antibodies specific therefor
10/05/1999US5961976 Monoclonal antibodies characterized by their ability to neutralize in vitro and in vivo primary isolates of human immunodeficiency virus (hiv) and related immunodeficiency viruses.
10/05/1999US5961975 Type I surface antigen associated with staphylococcus epidermidis
1 ... 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 ... 1494